Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)

The recruitment status of this study is unknown because the information has not been verified recently.

Verified February 2014 by Celsion.
Recruitment status was Active, not recruiting

Sponsor:

Information provided by (Responsible Party):

Celsion

ClinicalTrials.gov Identifier:

NCT00617981

First received: February 6, 2008

Last updated: February 3, 2014

Last verified: February 2014

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	December 2015
Primary Completion Date:	January 2013 (Final data collection date for primary outcome measure)